Orgenesis
$1.22
21
-$0.28-18.67% Hari ini
Statistik
Harga Tertinggi Hari Ini
1.55
Harga Terendah Hari Ini
1.12
52M Tinggi
10.8
52M Rendah
1.12
Volume
90,333
Rata-Rata Volume
37,155
Kap Pasar
31.44M
Rasio P/E
-
Hasil Dividen
-
Dividen
-
Mendatang
Pendapatan
8NovDiharapkan
EPS yang Diharapkan
0.17
EPS Aktual
T/A
Orang Juga Mengikuti
Daftar ini didasarkan pada daftar pantauan orang-orang di Stock Events yang mengikuti ORGS. Ini bukan rekomendasi investasi.
Peserta
Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
CRISPR Therapeutics
CRSP
Kap Pasar4.06B
Bluebird bio
BLUE
Kap Pasar108.22M
Sangamo Therapeutics
SGMO
Kap Pasar176.57M
Intellia Therapeutics
NTLA
Kap Pasar2.28B
Editas Medicine
EDIT
Kap Pasar308.46M
Pfizer
PFE
Kap Pasar164.39B
Biomarin Pharmaceutical
BMRN
Kap Pasar17.36B
Gilead Sciences
GILD
Kap Pasar98.35B
Adverum Biotechnologies
ADVM
Kap Pasar144.36M
Tentang
Health Technology
Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
Show more...
CEO
Vered Caplan
Karyawan
146
Negara
US
ISIN
US68619K2042